Atlas Trials

Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension

Clinical trial NCT04488978 · COMPLETED

Trial details

NCT number
NCT04488978
Sponsor
Handok Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2020-05-21
Primary completion
2021-11-09
Enrollment
440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.